Steven Shallcross | executive |
James Molloy | analyst |
Manel Cascalló | executive |
Vince Wacher | executive |
Greetings, and welcome to the Theriva Biologics, Inc. 2023 Third Quarter Operational Highlights and Financial Results. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Steve Shallcross. Thank you.
You may begin.